SECsense Logo

Processa Pharmaceuticals, Inc. 8-K Current Report - February 2025 Insights

$PCSA
Form 8-K
Filed on: 2025-02-10
Source
Processa Pharmaceuticals, Inc. 8-K Current Report - February 2025 Insights

Based on the provided XML section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Processa Pharmaceuticals, Inc.
  • CIK (Central Index Key): 0001533743
  • Company Identifier: DE (Delaware)
  • SEC File Number: 001-39531
  • EIN (Employer Identification Number): 45-1539785
  • Address: 7380 Coca Cola Drive, Suite 106, Hanover, MD 21076
  • Contact Number: (443) 776-3133
  1. Filing Information:
  • Form Type: 8-K (Current Report)
  • Filing Date: February 4, 2025
  1. Stock Information:
  • Type of Stock: Common stock
  • Par Value: $0.0001
  • Ticker Symbol: PCSA
  • Stock Exchange: NASDAQ
  1. Context Information:
  • Reporting Date: As of February 4, 2025
  • Period Start Date: February 4, 2025
  • Period End Date: February 4, 2025
  1. Measurement Units:
  • Currency: USD (U.S. Dollars)
  • Shares: The report makes reference to shares but does not provide numerical values in the provided section.

Summary

This section is a current report (Form 8-K) filed by Processa Pharmaceuticals, Inc. on February 4, 2025. It includes essential details about the company, stock information, and context for the report period. The filing indicates ongoing operations in the pharmaceutical sector, with shares listed on NASDAQ under the ticker symbol PCSA. The par value of the common stock is noted as $0.0001. Further financial details would require additional sections of the report.